Gosuranemab
- Generic Name
- Gosuranemab
- Drug Type
- Biotech
- CAS Number
- 1788032-39-2
- Unique Ingredient Identifier
- 09FZ7Q0PQZ
- Background
Gosuranemab is under investigation in clinical trial NCT02460094 (Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath